Hyperhomocysteinemia and thrombosis: Acquired conditions

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 527-531

  Selhub, Jacob ^a   D'Angelo, Armando ^b  

^a TUFTS UNIVERSITY   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; HOMOCYSTEINE; METHIONINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; BLOOD CLOTTING; CARDIOVASCULAR RISK; CONFERENCE PAPER; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; FOLIC ACID DEFICIENCY; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; THROMBOSIS; VEIN THROMBOSIS;

EID: 0030855797     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657582     Document Type: Conference Paper

References (24)

1. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1991 55:131-8.
2. Christensen B, Refsum H, Vintermyr O, Ueland PM. Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of nontransformed, transformed, proliferating, and quiescent cells in culture J Cell Biol 1991; 146:52-62.
3. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56:111.
4. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976; 57:1079-82.
5. Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease, In: Francis RBJ (ed). Atherosclerotic Cardiovascular Disease Hemostasis, and Endothelial Function. New York: Marcel Dekker 1992; pp 183-236.
6. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274:1049-57.
7. Hirsh J, Prins MH, Samama M. Approach to the thrombophilic patient in Colman RW, Hirsh J, Marder VJ, Salzman E (eds). Hemostasis and Thrombosis. Basic and Clinical Practice. Philadelphia: Lippincott Company 1994; p 1543.
8. Brattstrom L, Tengborn L, Lagerstedt C, Israelsson B, Hultberg B. Plasma homocysteine in venous thromboembolism. Haemostasis 1991; 21:51-7.
9. Amundsen T, Ueland PM, Waage A. Plasma homocysteine levels in patients with deep venous thrombosis. Arterioscler Thromb Vasc Biol 1995; 15:1321-3.
10. Bienvenue T, Ankri A, Chadefauz B, Montalescot G, Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis; relation to coagulation and fibrinolytic parameters. Thromb Res 1993; 70:123-9.
11. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocysteinemia in patients with juvenile venous thrombosis. Arterioscler Thromb 1994; 14: 1080-3.
12. Fermo I, Vigano, D'Angelo S, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 1995; 123:747-53.
13. den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ. Is hyperhomocysteinemia a risk factor for recurrent thrombosis? Lancet 1995; 345:882-5.
14. den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ. Hyperhomocysteinemia as a risk factor for deep vein thrombosis. N Engl J Med 1996; 334:759-62.
15. Cattaneo M, Martinelli I, Mannucci PM. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 335:974-5 (letter).
16. Simloni P, Prandoni P, Burilina A, Tormene D, Sardella C, Ferrari V, Beneditti L, Girolami A. Hyperhomocysteinemia and deep-vein thrombosis. A case control study. Thromb Haemos 1996; 76:883.
17. Petri M, Roubenoff R, Dallai GE, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteoine as a risk factor for atherothrombotic events in systemic lupus erythmatosus. Lancet 1996; 348:1120.
18. Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jakobs C, Fowler B, Seligsohn U. Coexistence of hereditary homocystinuria and factor V Leiden - effect on thrombosis. N Engl J Med 1996; 334:763-8.
19. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, Factor V Leiden, and risks of future venous thrombosis. Circulation, in press.
20. D'Angelo A, Fermo I, Vigano, D'Angelo S. Coexistence of hereditary homocystinuria and factor V Leiden - effect on thrombosis. N Engl J Med 1996; 335:288 (letter).
21. Harpel PC, Zhang X, Borth W. Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutrition 1996; 4(Suppl):1285S-9S.
22. Upchurch GR Jr, Welch BH, Loscalzo J. Homocysteine, EDRF, and endothelial function. J Nutrition 1996; 126(4 Suppl): 1290S-4S.
23. Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993; 71:337-59.
24. Mayer EL, Jacobsen DE, Robinson K. Homocysteine and coronary atherosclerosis. J Amer Coll Cardiol 1996; 27:517-27.